KATHERINE SPRADLEY: Open Payments
NPI 1326787615 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$114 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $240 · 2025 $114
Food & beverage: $114
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: AIRSUPRA, FANAPT, REXULTI, MOUNJARO, JARDIANCE, FARXIGA.
Industry payments across IN — which companies pay providers there.
